First human tests begin for promising new cancer treatment
NCT ID NCT07223125
Summary
This early-stage study is testing a new experimental drug called JNJ-89862175 for people with advanced solid tumors that have spread or cannot be surgically removed. The trial aims to find safe and effective doses by enrolling 360 participants with specific cancers including lung, kidney, ovarian, and uterine tumors. Researchers will closely monitor side effects and how the drug behaves in the body to determine if it should move to larger studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED-STAGE SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AdventHealth Orlando
RECRUITINGOrlando, Florida, 32803, United States
-
Centre Leon Berard
RECRUITINGLyon, 69373, France
-
Gustave Roussy
RECRUITINGVillejuif, 94805, France
-
NEXT Oncology
RECRUITINGIrving, Texas, 75039, United States
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
Conditions
Explore the condition pages connected to this study.